NOUL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,705 KRW | -5.75% |
|
+6.92% | -33.37% |
| Apr. 25 | Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference | CI |
| 2023 | Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 98,500 | 150,005 |
| Enterprise Value (EV) 1 | 98,641 | 138,193 |
| P/E ratio | -6.92 x | -6.66 x |
| Yield | - | - |
| Capitalization / Revenue | 182 x | 54.9 x |
| EV / Revenue | 182 x | 50.5 x |
| EV / EBITDA | -7.09 x | -9.69 x |
| EV / FCF | -8.5 x | -13.2 x |
| FCF Yield | -11.8% | -7.59% |
| Price to Book | 8.64 x | 3.49 x |
| Nbr of stocks (in thousands) | 22,907 | 36,947 |
| Reference price 2 | 4,300 | 4,060 |
| Announcement Date | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 1,475 | 541.9 | 2,734 |
| EBITDA 1 | -10,214 | -13,922 | -14,268 |
| EBIT 1 | -11,438 | -15,632 | -16,139 |
| Operating Margin | -775.29% | -2,884.82% | -590.33% |
| Earnings before Tax (EBT) 1 | -12,296 | -13,675 | -16,320 |
| Net income 1 | -12,313 | -13,680 | -16,321 |
| Net margin | -834.61% | -2,524.55% | -597% |
| EPS 2 | -785.5 | -621.5 | -609.2 |
| Free Cash Flow 1 | -7,653 | -11,602 | -10,491 |
| FCF margin | -518.75% | -2,141.15% | -383.74% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/22/22 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 4,734 | 140 | - |
| Net Cash position 1 | - | - | 11,812 |
| Leverage (Debt/EBITDA) | -0.4635 x | -0.0101 x | - |
| Free Cash Flow 1 | -7,653 | -11,602 | -10,491 |
| ROE (net income / shareholders' equity) | 228% | -206% | -60% |
| ROA (Net income/ Total Assets) | -40.2% | -42.7% | -24.8% |
| Assets 1 | 30,593 | 32,073 | 65,879 |
| Book Value Per Share 2 | 105.0 | 497.0 | 1,164 |
| Cash Flow per Share 2 | 11.00 | 89.20 | 179.0 |
| Capex 1 | 508 | 2,170 | 207 |
| Capex / Sales | 34.41% | 400.46% | 7.57% |
| Announcement Date | 3/22/22 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -33.37% | 73.17M | |
| -27.70% | 9.87B | |
| +27.06% | 2.89B | |
| -16.78% | 2.75B | |
| -15.31% | 2.13B | |
| -21.41% | 1.65B | |
| +68.70% | 1.47B | |
| +29.75% | 811M | |
| -5.02% | 733M | |
| -29.39% | 510M |
- Stock Market
- Equities
- A376930 Stock
- Financials Noul Co.,Ltd.
